2-amido-6-amino-8-oxopurine derivatives as Toll-Like receptor modulators for the treatment of cancer and viral infections, such as hepatitis C

Details for Australian Patent Application No. 2006242920 (hide)

Owner Pfizer Limited

Inventors Pryde, David Cameron; Jones, Peter

Agent Shelston IP

Pub. Number AU-A-2006242920

PCT Pub. Number WO2006/117670

Priority 60/678,054 04.05.05 US

Filing date 24 April 2006

Wipo publication date 9 November 2006

International Classifications

C07D 473/34 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61K 31/522 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/117670 Priority application(s): WO2006/117670

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242927-Androgen modulators

2006242914-New DHA derivatives and their use as medicaments